When will the Vigabatrin Tablet shortage end?

FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.

Does FDA list alternatives to Vigabatrin Tablet?

No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.

Is Vigabatrin Tablet being discontinued?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

DISCONTINUATION NOTICE

Vigabatrin Tablet: 1 maker discontinuing

Tablets

A generic tablet, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.

DRUG

Vigabatrin Tablet

FDA LISTING

Vigabatrin Tablet

FORM

tablets

STATUS

Discontinuation

FIRST POSTED

Oct 16, 2026

LAST FDA UPDATE

Oct 16, 2026

AS OF

Oct 24, 2026

SOURCE

FDA Drug Shortages ↗ (opens in a new tab)

1 discontinuation notice below, in FDA's words. A discontinuation “does not necessarily create a shortage” (FDA).

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Vigabatrin Tablet. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
Is my strength or the maker you stock affected? FDA list, by presentation
Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Discontinuation notices

A discontinuation “does not necessarily create a shortage” (FDA).

Hikma Pharmaceuticals USA, Inc. told FDA it will discontinue Vigabatrin (posted Oct 16, 2026).
“The decision to discontinue this drug product was due to a business decision and not due to any reasons of safety or effectiveness.”
FDA listing: Vigabatrin Tablet

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Vigabatrin Tablet being discontinued?: As of Oct 24, 2026, FDA lists discontinuation notices for Vigabatrin Tablet, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).
When will the Vigabatrin Tablet shortage end?: FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Vigabatrin Tablet?: No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.